UNSPSC 51282103: Azidocillin

This classification denotes a penicillin antibiotic with the molecular formula C16H17N5O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R8XDP7L3SL, chemically known as 6-(2-azido-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-4-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as azidocillin, which bears US NIH Compound Identifier 71886. Azidocillin most often comes in base, natrium, and sodium forms.

UNSPSC 51282103 Azidocillin is a Commodity code, but the recent state and local opportunities posted under it do not reflect procurement of azidocillin or other penicillin-class antibiotics. Instead, the two recent records show awards and solicitations for unrelated pharmaceutical products: a completed piggyback contract for doxycycline and ciprofloxacin through Illinois Department of Public Health, and an open IFB from Seminole County, Florida for naloxone and drug deactivation systems. The code shows little relevant recent activity aligned with its nominal pharmaceutical scope.

The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 (Bid 26-482DPH-PREPD-B-53392) for doxycycline hyclate 100mg tablets and ciprofloxacin hydrochloride 500mg tablets across a 12-month initial term with two one-year renewal options. Seminole County, Florida released an IFB (IFB60459723LAS) on June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, under a two-year initial term plus one-year renewal option; the response deadline was July 26, 2026 at 2:00 pm. Neither solicitation targets the azidocillin Commodity code's actual scope, suggesting the code may be misclassified by the issuing agencies or that state and local azidocillin procurement is not currently visible in public-facing opportunity postings.